Beam Therapeutics

Beam Therapeutics

Biotechnology, 238 Main St Ste 9, Cambridge, Massachusetts, 02142, United States, 501-1000 Employees

beamtx.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 85********

Who is BEAM THERAPEUTICS

Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology al...

Read More

map
  • 238 Main St Ste 9, Cambridge, Massachusetts, 02142, United States Headquarters: 238 Main St Ste 9, Cambridge, Massachusetts, 02142, United States
  • 2017 Date Founded: 2017
  • 501-1000 Employees: 501-1000
  • dollar-icon Revenue: $50 Million to $100 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541330 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from BEAM THERAPEUTICS

Beam Therapeutics Org Chart and Mapping

Employees

Elaine Wong

Director, Product and Portfolio Strategy, Genetic Diseases

Layne Jacobs

Vice President, Corporate Counsel

Mark Manfredi

Director of Operations

Chamara Jayesinghe

Director, Beam-201 Program Lead

Ameya Apte

Scientist in Vivo Pharmacology

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Beam Therapeutics

Answer: Beam Therapeutics's headquarters are located at 238 Main St Ste 9, Cambridge, Massachusetts, 02142, United States

Answer: Beam Therapeutics's phone number is 85********

Answer: Beam Therapeutics's official website is https://beamtx.com

Answer: Beam Therapeutics's revenue is $50 Million to $100 Million

Answer: Beam Therapeutics's SIC: 2836

Answer: Beam Therapeutics's NAICS: 541330

Answer: Beam Therapeutics has 501-1000 employees

Answer: Beam Therapeutics is in Biotechnology

Answer: Beam Therapeutics contact info: Phone number: 85******** Website: https://beamtx.com

Answer: Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of precision genetic medicines, combining precision targeting of the genome with precision control of editing outcomes. Our dream is to provide life-long cures for patients suffering from serious diseases. The Beam Team Is: A community of fearless innovators Rigorous and honest in our research Listening with open minds Committed to each other

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access